Merck (MRK) Receivables - Net (2009 - 2026)
Merck (MRK) posted quarterly Receivables - Net of $12.2 billion for Q1 2026, up 13.16% year-over-year from $10.8 billion in Q1 2025, and up 3.69% quarter-over-quarter from $11.8 billion in Q4 2025.
Merck (MRK) Receivables - Net (2009 - 2026) Analysis & Trends
Merck (MRK) has reported Receivables - Net for 18 consecutive years, with $12.2 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Net rose 13.16% year-over-year to $12.2 billion; the TTM figure through Mar 2026 stood at $12.2 billion (up 13.16% YoY), while the FY2025 annual figure was $11.8 billion, up 14.57% from the prior year.
- Receivables - Net advanced to $12.2 billion in Q1 2026 per MRK's latest filing, from $11.8 billion in the prior quarter.
- Across five years, Receivables - Net topped out at $12.2 billion in Q1 2026 and bottomed at $9.5 billion in Q4 2022.
- Historically, Receivables - Net has averaged $10.8 billion across 5 years, with a median of $10.8 billion in 2025.
- Annual changes were most pronounced in 2022 — Receivables - Net jumped 4625.0% — and 2025, when it decreased 5.07%.
- Merck's Receivables - Net stood at $9.5 billion in 2022, then advanced by 9.51% to $10.3 billion in 2023, then fell by 0.69% to $10.3 billion in 2024, then advanced by 14.57% to $11.8 billion in 2025, then grew by 3.69% to $12.2 billion in 2026.
- Business Quant data shows MRK's Receivables - Net at $12.2 billion in Q1 2026, $11.8 billion in Q4 2025, and $12.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.49 Bn | 632.73 Bn | 17.26 Bn |
| 2 | AbbVie | 470.91 Bn | 464.34 Bn | 12.70 Bn |
| 3 | Merck | 379.63 Bn | 372.49 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.14 Bn | 295.45 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.40 Bn | 253.50 Bn | 12.86 Bn |
| 6 | Amgen | 237.10 Bn | 223.11 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 183.02 Bn | 179.84 Bn | 6.22 Bn |
| 8 | Pfizer | 161.60 Bn | 149.90 Bn | 10.94 Bn |
| 9 | Gsk | 105.86 Bn | 101.70 Bn | 8.24 Bn |
| 10 | Sanofi | 55.22 Bn | 47.84 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.56 Bn |
| Jun 30, 2026 | 12.56 Bn |
| Mar 31, 2026 | 12.21 Bn |
| Mar 31, 2026 | 12.21 Bn |
| Dec 31, 2025 | 11.78 Bn |
| Dec 31, 2025 | 11.78 Bn |
| Sep 30, 2025 | 12.12 Bn |
| Sep 30, 2025 | 12.12 Bn |
| Jun 30, 2025 | 11.85 Bn |
| Jun 30, 2025 | 11.85 Bn |
| Mar 31, 2025 | 10.79 Bn |
| Mar 31, 2025 | 10.79 Bn |
| Dec 31, 2024 | 10.28 Bn |
| Dec 31, 2024 | 10.28 Bn |
| Sep 30, 2024 | 11.38 Bn |
| Sep 30, 2024 | 11.38 Bn |
| Jun 30, 2024 | 11.64 Bn |
| Jun 30, 2024 | 11.64 Bn |
| Mar 31, 2024 | 11.37 Bn |
| Mar 31, 2024 | 11.37 Bn |